Prion diseases are caused by the transconformation of the host cellular
prion protein PrP(c) into an infectious neurotoxic
isoform called PrP(Sc). While
vaccine-induced PrP-specific CD4(+) T cells and
antibodies partially protect
scrapie-infected mice from disease, the potential autoreactivity of CD8(+) cytotoxic T lymphocytes (CTLs) received little attention. Beneficial or pathogenic influence of PrP(c)-specific CTL was evaluated by stimulating a CD8(+) T-cell-only response against PrP in
scrapie-infected C57BL/6 mice. To circumvent immune tolerance to PrP, five PrP-derived nonamer
peptides identified using prediction algorithms were anchored-optimized to improve binding affinity for H-2D(b) and immunogenicity (NP-
peptides). All of the NP-
peptides elicited a significant number of IFNγ secreting CD8(+) T cells that better recognized the NP-
peptides than the natives; three of them induced T cells that were lytic in vivo for NP-
peptide-loaded target cells.
Peptides 168 and 192 were naturally processed and presented by the 1C11 neuronal cell line. Minigenes encoding immunogenic NP-
peptides inserted into adenovirus (rAds) vectors enhanced the specific CD8(+) T-cell responses. Immunization with rAd encoding 168NP before
scrapie inoculation significantly prolonged the survival of infected mice. This effect was attributable to a significant lengthening of the symptomatic phase and was associated with enhanced CD3(+) T cell recruitment to the CNS. However, immunization with Ad168NP in
scrapie-incubating mice induced IFNγ-secreting CD8(+) T cells that were not cytolytic in vivo and did not influence
disease progression nor infiltrated the brain. In conclusion, the data suggest that
vaccine-induced PrP-specific CD8(+) T cells interact with
prions into the CNS during the clinical phase of the disease.